efficacy of oral tirzepatide tirzepatide: what actually exists, what does not, and what is coming next Oral Tirzepatide Pill: FDA-Approved Options

Abstract The global prevalence of obesity is rapidly in creasing, significantly increasing the incidence of heart failure with preserved ejection fraction (HFpEF)

When you lose weight rapidly, this facial fat decreases along with body fat, leading to hollowed cheeks and temples

Discard damaged medication and contact PlexusDx for replacement

Patients with Tetralogy are at increased risk of both atrial and ventricular arrhythmias

We create a long-term strategy to help you transition off medication safely while maintaining your progress

10.1038/onc.2017.38 Summary Keywords alcohol-associated liver disease (ALD), glucagon-like peptide 1 receptor agonists (GLP-1 RAs), metabolic dysfunction and alcohol-associated liver disease (MetALD), metabolic dysfunction-associated steatotic liver disease (MASLD), steatotic liver disease (SLD) Citation Mahalingam S, Kharbanda KK, Casey CA and Rasineni K (2026) Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum